Cardiol Therapeutics Inc. (CRDL) Form 6-K — May 26, 2026
Cardiol Therapeutics Inc. filed a 6-K containing its management information circular for the annual meeting of shareholders, detailing board composition and voting securities. The filing confirms that MM Asset Management Inc., on behalf of MMCAP International Inc. SPC, holds approximately 13.3% of outstanding shares and warrants representing an additional 17.4% on a partially diluted basis.
Key figures
- Shares Outstanding
- 115272240
- Major Shareholder Shares
- 15352317
- Major Shareholder Percent
- 13.3
- Available For Future Issuance
- 7503768
- Outstanding Options RSUs PSUs
- 9787068
- Weighted Average Exercise Price
- 1.73
- Major Shareholder Warrant Shares
- 5711539
- Major Shareholder Warrant Percent
- 17.4
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.